Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging innovations on exosome-based onco-therapeutics
Xiaofeng Dai, Yongju Ye, Fu-le He
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20

Showing 20 citing articles:

NK cell-derived exosomes enhance the anti-tumor effects against ovarian cancer by delivering cisplatin and reactivating NK cell functions
Heyong Luo, Yanhua Zhou, Jing Zhang, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 53
Potential Pathophysiological Pathways in the Complex Relationships between OSA and Cancer
Manuel Sánchez‐de‐la‐Torre, Carolina Cubillos‐Zapata, Olivia J. Veatch, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1061-1061
Open Access | Times Cited: 24
Exosome-like systems: Nanotechnology to overcome challenges for targeted cancer therapies
Jenifer García-Fernández, María de la Fuente
Cancer Letters (2023) Vol. 561, pp. 216151-216151
Closed Access | Times Cited: 22
Exploring the clinical transition of engineered exosomes designed for intracellular delivery of therapeutic proteins
Minseong Kim, Hojun Choi, Deok-Jin Jang, et al.
Stem Cells Translational Medicine (2024) Vol. 13, Iss. 7, pp. 637-647
Open Access | Times Cited: 9
Patient-Derived Exosomes as siRNA Carriers in Ovarian Cancer Treatment
Aasa Shimizu, Kenjiro Sawada, Masaki Kobayashi, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1482-1482
Open Access | Times Cited: 7
Standardized Reporting of Research on Exosomes to Ensure Rigor and Reproducibility
Anita Yadav, Yi Xuan, Chandan K. Sen, et al.
Advances in Wound Care (2024) Vol. 13, Iss. 11, pp. 584-599
Closed Access | Times Cited: 7
Extracellular vesicles biogenesis, isolation, manipulation and genetic engineering for potential in vitro and in vivo therapeutics: An overview
Nastaran Hadizadeh, Diba Bagheri, Mehdi Shamsara, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 23
Role of exosomes in non-small cell lung cancer and EGFR-mutated lung cancer
Dingyu Rao, Defa Huang, Mao-Yan Si, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Portrait of WWP1: the current state in human cancer
Jiaming Lei, Jun Chen, Wenwen Yu, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
Oxaliplatin-loaded natural killer cell-derived exosomes for a safe and efficient chemoimmunotherapy of colorectal cancer
Han Yu, Weicheng Zheng, Y. S. Zhang, et al.
Journal of Pharmaceutical Sciences (2025), pp. 103783-103783
Closed Access
Targeted drug delivery in neurodegenerative diseases: the role of nanotechnology
Rupal Dhariwal, Mukul Jain, Y. Mir, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Unravelling the therapeutic properties of aptamer-modified exosome nanocomposite
Simran Makkar, Niket Rana, Nitesh Priyadarshi, et al.
Advances in Colloid and Interface Science (2025), pp. 103517-103517
Closed Access
Crosstalk between colorectal cancer cells and cancer-associated fibroblasts in the tumor microenvironment mediated by exosomal noncoding RNAs
Shichen Sun, Yanyu Zhang, Yubing Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
A clinically relevant large‐scale biomanufacturing workflow to produce natural killer cells and natural killer cell‐derived extracellular vesicles for cancer immunotherapy
Frédéric St-Denis Bissonnette, Sarah E. Cummings, Shirley Qiu, et al.
Journal of Extracellular Vesicles (2023) Vol. 12, Iss. 12
Open Access | Times Cited: 5
CRISPR-Cas-based biosensors for the detection of cancer biomarkers
Yuxin Feng, J. Yang, Ziping He, et al.
Analytical Methods (2024) Vol. 16, Iss. 39, pp. 6634-6653
Closed Access | Times Cited: 1
Hypoxia exosome derived CEACAM5 promotes tumor‐associated macrophages M2 polarization to accelerate pancreatic neuroendocrine tumors metastasis via MMP9
Mujie Ye, Feiyu Lu, Danyang Gu, et al.
The FASEB Journal (2024) Vol. 38, Iss. 13
Closed Access | Times Cited: 1
Large-scale Isolation of Exosomes Derived from NK Cells for Anti-tumor Therapy
Heyong Luo, Jing Zhang, Anqing Yang, et al.
BIO-PROTOCOL (2023) Vol. 13, Iss. 11
Open Access | Times Cited: 2
Circulating exosomes in sepsis: A potential role as diagnostic biomarkers, therapeutic and drug delivery carriers
Roushka Bhagwan Valjee, Usri H. Ibrahim, Kwanele Xulu, et al.
Smart Materials in Medicine (2023) Vol. 4, pp. 639-647
Open Access | Times Cited: 2
The biological roles of exosome-encapsulated traditional Chinese medicine monomers in neuronal disorders
Pang Chen, Jie Zhang, Yujin Gu, et al.
Journal of Pharmaceutical Analysis (2024), pp. 101131-101131
Open Access
Exosome applications for the diagnosis and treatment of pancreatic ductal adenocarcinoma: An update (Review)
Xinchi Luan, Xuezhe Wang, Gang Bian, et al.
Oncology Reports (2024) Vol. 53, Iss. 1
Open Access
Potential targets of natural medicines: preventing lung cancer pre-metastatic niche formation by regulating exosomes
Xiaoyu Zhu, Jie Li
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
Page 1

Scroll to top